Sinopharm Group Balance Sheet Health
Financial Health criteria checks 4/6
Sinopharm Group has a total shareholder equity of CN¥122.9B and total debt of CN¥77.3B, which brings its debt-to-equity ratio to 62.9%. Its total assets and total liabilities are CN¥413.1B and CN¥290.2B respectively. Sinopharm Group's EBIT is CN¥21.7B making its interest coverage ratio 9.9. It has cash and short-term investments of CN¥48.9B.
Key information
62.9%
Debt to equity ratio
CN¥77.26b
Debt
Interest coverage ratio | 9.9x |
Cash | CN¥48.91b |
Equity | CN¥122.86b |
Total liabilities | CN¥290.20b |
Total assets | CN¥413.07b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SHTD.Y's short term assets (CN¥364.5B) exceed its short term liabilities (CN¥268.0B).
Long Term Liabilities: SHTD.Y's short term assets (CN¥364.5B) exceed its long term liabilities (CN¥22.2B).
Debt to Equity History and Analysis
Debt Level: SHTD.Y's net debt to equity ratio (23.1%) is considered satisfactory.
Reducing Debt: SHTD.Y's debt to equity ratio has increased from 56.9% to 62.9% over the past 5 years.
Debt Coverage: SHTD.Y's debt is not well covered by operating cash flow (13.4%).
Interest Coverage: SHTD.Y's interest payments on its debt are well covered by EBIT (9.9x coverage).